{"id":"antithrombotic-agent","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Hemorrhage"},{"rate":null,"effect":"Gastrointestinal bleeding"}]},"_chembl":{"chemblId":"CHEMBL4802227","moleculeType":"Small molecule","molecularWeight":"274.11"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antithrombotic agents work through multiple mechanisms including platelet inhibition (e.g., antiplatelet drugs like aspirin or P2Y12 inhibitors), anticoagulation (e.g., warfarin, direct oral anticoagulants), or thrombin inhibition. These drugs reduce the risk of pathological thrombosis in arterial and venous systems by interfering with hemostatic mechanisms.","oneSentence":"Antithrombotic agents prevent blood clot formation by inhibiting platelet aggregation or coagulation cascade pathways.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:17:29.023Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Thrombotic and thromboembolic disorders (general class indication)"}]},"trialDetails":[{"nctId":"NCT05907694","phase":"NA","title":"Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure","status":"RECRUITING","sponsor":"Josep Rodes-Cabau","startDate":"2024-06-18","conditions":"Patent Foramen Ovale, Cryptogenic Stroke, Older Patients","enrollment":714},{"nctId":"NCT04790370","phase":"PHASE4","title":"Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2021-08-02","conditions":"Pulmonary Embolism","enrollment":544},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07471256","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Intracerebral Hemorrhage Lobar","enrollment":636},{"nctId":"NCT07452991","phase":"NA","title":"ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2024-09-10","conditions":"Pulmonary Embolism (PE)","enrollment":300},{"nctId":"NCT06990867","phase":"PHASE2, PHASE3","title":"Optimizing Reperfusion to Improve Outcomes and Neurologic Function","status":"RECRUITING","sponsor":"Corxel Pharmaceuticals","startDate":"2025-05-15","conditions":"Acute Ischemic Stroke","enrollment":740},{"nctId":"NCT07187687","phase":"NA","title":"TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-10-24","conditions":"Intracerebral Hemorrhage","enrollment":750},{"nctId":"NCT07007143","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-07-31","conditions":"Mitral Regurgitation","enrollment":1032},{"nctId":"NCT06975969","phase":"","title":"Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter","status":"WITHDRAWN","sponsor":"Liquet Medical Inc.","startDate":"2025-09-05","conditions":"Blood Clots, Vascular Disease, Embolism Thrombosis","enrollment":""},{"nctId":"NCT07430917","phase":"PHASE2","title":"Safety and Efficacy of J147 in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Abrexa Pharmaceuticals, Inc.","startDate":"2026-03-20","conditions":"Acute Ischemic Stroke","enrollment":196},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT07424378","phase":"PHASE4","title":"Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02","conditions":"Frostbite","enrollment":66},{"nctId":"NCT07411079","phase":"","title":"Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Intracerebral Hemorrhage, Hemorrhagic Risk Conditions, Bleeding Disorders","enrollment":1126},{"nctId":"NCT07389460","phase":"PHASE3","title":"Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":820},{"nctId":"NCT06196307","phase":"","title":"Early Warning and Classification Model for Acute Non-traumatic Chest Pain","status":"RECRUITING","sponsor":"Xiao-nan He","startDate":"2022-08-30","conditions":"Chest Pain","enrollment":10000},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT07084051","phase":"NA","title":"Improve Medication Adherence Among Stroke Survivors in Rural Kentucky","status":"COMPLETED","sponsor":"Hend Mansoor","startDate":"2025-07-24","conditions":"Stroke (CVA) or Transient Ischemic Attack","enrollment":4},{"nctId":"NCT07339956","phase":"EARLY_PHASE1","title":"Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2026-01-10","conditions":"Gastrointestinal Bleeding","enrollment":60},{"nctId":"NCT06535568","phase":"NA","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","status":"RECRUITING","sponsor":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","startDate":"2026-01-10","conditions":"Coronary Disease, Heart Diseases, Cardiovascular Diseases","enrollment":576},{"nctId":"NCT06949228","phase":"PHASE2, PHASE3","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial","status":"RECRUITING","sponsor":"ProMedica Health System","startDate":"2025-07-30","conditions":"Ischemic Stroke, Acute Disease","enrollment":132},{"nctId":"NCT07338071","phase":"","title":"Antithrombotic Therapy at the End of Life: The PEACE Study","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01","conditions":"Palliative Care","enrollment":410},{"nctId":"NCT07271342","phase":"","title":"Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-11-30","conditions":"Stroke","enrollment":10000},{"nctId":"NCT00147316","phase":"PHASE3","title":"Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2002-04","conditions":"Cerebral Infarction, Brain Ischemia","enrollment":103},{"nctId":"NCT06994975","phase":"PHASE3","title":"CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-03","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT07295366","phase":"PHASE4","title":"Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2025-11-18","conditions":"Acute Stroke","enrollment":60},{"nctId":"NCT07241130","phase":"","title":"Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-02-01","conditions":"Pulmonary Embolism Acute","enrollment":120},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT03263117","phase":"PHASE4","title":"SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-07-01","conditions":"Stroke","enrollment":260},{"nctId":"NCT05111613","phase":"NA","title":"The PEERLESS Study","status":"COMPLETED","sponsor":"Inari Medical","startDate":"2022-02-14","conditions":"Pulmonary Embolism, Pulmonary Thromboembolism","enrollment":692},{"nctId":"NCT07208695","phase":"","title":"Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2025-10-01","conditions":"Oral Antiplatele, Anticoagulant Drugs, Lower Extremity Varicose Veins","enrollment":40},{"nctId":"NCT03957707","phase":"NA","title":"Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2019-01-01","conditions":"Basal Ganglia Haematoma","enrollment":380},{"nctId":"NCT03335839","phase":"PHASE3","title":"Adjunctive, Low-dose tPA in Primary PCI for STEMI","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2018-04-01","conditions":"Myocardial Infarction, Percutaneous Coronary Intervention","enrollment":210},{"nctId":"NCT07160491","phase":"NA","title":"Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI","status":"RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2025-09-08","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":3356},{"nctId":"NCT06320431","phase":"PHASE3","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-09-26","conditions":"Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic","enrollment":4000},{"nctId":"NCT05797792","phase":"PHASE3","title":"CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-11-18","conditions":"Stroke, Acute Ischemic, Stroke, Acute","enrollment":440},{"nctId":"NCT07151755","phase":"NA","title":"Microneedle Intra-Arterial Injection for Retinal Artery Occlusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Central Retinal Artery Occlusion","enrollment":24},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT07146360","phase":"PHASE3","title":"Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2014-05-25","conditions":"Myocardial Infarction (MI)","enrollment":180},{"nctId":"NCT07139639","phase":"EARLY_PHASE1","title":"Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease","status":"NOT_YET_RECRUITING","sponsor":"Zheng Liu","startDate":"2025-11-01","conditions":"Diabetic Lower Extremity Arterial Disease","enrollment":350},{"nctId":"NCT07119021","phase":"PHASE4","title":"Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)","status":"RECRUITING","sponsor":"Ruijun Ji","startDate":"2024-08-01","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT06052969","phase":"NA","title":"Pulse Endovascular ReperFUSION for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Euphrates Vascular, Inc.","startDate":"2023-10-01","conditions":"Acute Ischemic Stroke AIS, Cerebral Arterial Disease","enrollment":8},{"nctId":"NCT06440707","phase":"PHASE2","title":"Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-07-15","conditions":"Acute Ischemic Stroke","enrollment":120},{"nctId":"NCT05892510","phase":"PHASE2, PHASE3","title":"Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2024-06-01","conditions":"Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder","enrollment":462},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT05032053","phase":"","title":"Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2022-03-01","conditions":"Ischemic Stroke","enrollment":3000},{"nctId":"NCT04785651","phase":"NA","title":"Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies","status":"TERMINATED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2021-02-22","conditions":"Monocompartimental Tibiofemoral Osteoarthritis, Osteoarthritis","enrollment":49},{"nctId":"NCT05077124","phase":"","title":"Safe and Timely Antithrombotic Removal (STAR) Registry","status":"RECRUITING","sponsor":"CytoSorbents, Inc","startDate":"2021-09-30","conditions":"Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical","enrollment":1000},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT07032025","phase":"EARLY_PHASE1","title":"Mechanical Thrombectomy for Acute Pulmonary Embolism","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-07-01","conditions":"Acute Pulmonary Embolism","enrollment":200},{"nctId":"NCT05622500","phase":"NA","title":"Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2022-09-03","conditions":"Chronic Venous Insufficiency, Chronic Venous Thrombosis, Iliac Vein Stenosis","enrollment":12},{"nctId":"NCT05591118","phase":"PHASE3","title":"Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-07-17","conditions":"Pulmonary Embolism","enrollment":500},{"nctId":"NCT06993636","phase":"","title":"Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-01-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban","enrollment":60},{"nctId":"NCT04430569","phase":"PHASE3","title":"Pulmonary Embolism International THrOmbolysis Study-3","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-08-04","conditions":"Pulmonary Embolism","enrollment":800},{"nctId":"NCT02594813","phase":"","title":"Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents","status":"RECRUITING","sponsor":"Showa Inan General Hospital","startDate":"2015-11","conditions":"Bleeding After GI Endoscopy","enrollment":10000},{"nctId":"NCT03881345","phase":"","title":"Ongoing Registry of Treatment of Venous Thromboembolism","status":"RECRUITING","sponsor":"Medalp Private Surgery Clinic","startDate":"2019-04-01","conditions":"Deep Vein Thrombosis, Thromboses, Venous, Thrombosis Embolism","enrollment":5000},{"nctId":"NCT06868511","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-25","conditions":"Deep Intracerebral Hemorrhage (ICH)","enrollment":732},{"nctId":"NCT04976530","phase":"NA","title":"Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)","status":"COMPLETED","sponsor":"CytoSorbents, Inc","startDate":"2021-08-31","conditions":"Hemorrhage, Surgical, Blood Loss, Surgical, Blood Loss, Postoperative","enrollment":140},{"nctId":"NCT03192215","phase":"PHASE3","title":"AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke","status":"TERMINATED","sponsor":"Columbia University","startDate":"2018-01-19","conditions":"Stroke","enrollment":1015},{"nctId":"NCT06434324","phase":"NA","title":"Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-03-29","conditions":"Pleural Infection","enrollment":60},{"nctId":"NCT05172934","phase":"PHASE2","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial","status":"COMPLETED","sponsor":"ProMedica Health System","startDate":"2022-03-15","conditions":"Ischemic Stroke","enrollment":20},{"nctId":"NCT05895136","phase":"PHASE2","title":"A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).","status":"RECRUITING","sponsor":"European Foundation for Study of Chronic Liver Failure","startDate":"2024-07-01","conditions":"Liver Cirrhosis, Decompensated Cirrhosis of Liver, Acute on Chronic Liver Failure (ACLF)","enrollment":90},{"nctId":"NCT06541691","phase":"NA","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","status":"RECRUITING","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2024-03-06","conditions":"Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Ischemic Heart Disease","enrollment":3000},{"nctId":"NCT04347200","phase":"","title":"REGistry of Long-term AnTithrombotic TherApy-1","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2015-01-15","conditions":"Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease","enrollment":2000},{"nctId":"NCT06660719","phase":"PHASE3","title":"Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care","status":"RECRUITING","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2025-02-14","conditions":"Ischemic Stroke","enrollment":852},{"nctId":"NCT05353140","phase":"NA","title":"LAAO Versus NOAC in Patients with AF and PCI","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2022-09-01","conditions":"Atrial Fibrillation, Percutaneous Coronary Intervention","enrollment":1386},{"nctId":"NCT06115070","phase":"PHASE4","title":"Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Thrombosis, Acute Ischemic Stroke (AIS)","enrollment":390},{"nctId":"NCT06510634","phase":"","title":"Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-06-01","conditions":"Stroke, Ischemic","enrollment":236},{"nctId":"NCT06814964","phase":"PHASE1","title":"rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-03-01","conditions":"Intraventricular Hemorrhage","enrollment":18},{"nctId":"NCT04650087","phase":"PHASE3","title":"COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis","status":"COMPLETED","sponsor":"Thomas L. Ortel","startDate":"2021-02-15","conditions":"Covid19","enrollment":1291},{"nctId":"NCT06841965","phase":"PHASE3","title":"Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06749834","phase":"PHASE3","title":"Intravenous Thrombolysis and NOAC","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-27","conditions":"Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06841978","phase":"PHASE3","title":"Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":306},{"nctId":"NCT03167281","phase":"PHASE4","title":"Early Intrapleural TPA Instillation Versus Late","status":"WITHDRAWN","sponsor":"Prisma Health-Midlands","startDate":"2017-02-17","conditions":"Tissue Plasminogen Activator","enrollment":""},{"nctId":"NCT06833827","phase":"NA","title":"'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-02","conditions":"Pulmonary Embolism Acute","enrollment":111},{"nctId":"NCT06418633","phase":"NA","title":"Variations in the Hemostatic System Induced by a Standardized Walking Test","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2025-02-11","conditions":"Venous Thromboembolism","enrollment":94},{"nctId":"NCT03186729","phase":"PHASE4","title":"Study of Antithrombotic Treatment After IntraCerebral Haemorrhage","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2018-07-01","conditions":"Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation","enrollment":134},{"nctId":"NCT03243175","phase":"PHASE3","title":"Avoiding Anticoagulation After IntraCerebral Haemorrhage","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2019-01-17","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation, Microhaemorrhage","enrollment":300},{"nctId":"NCT06812000","phase":"","title":"Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2024-04-14","conditions":"Post-stroke Seizure, Post-stroke Epilepsy, Thrombolytic (t-PA) Treatment","enrollment":199},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT04250116","phase":"PHASE4","title":"Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2020-04-28","conditions":"Atrial Fibrillation","enrollment":960},{"nctId":"NCT04454788","phase":"PHASE3","title":"Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion","status":"TERMINATED","sponsor":"University of Melbourne","startDate":"2020-08-01","conditions":"Ischemic Stroke","enrollment":242},{"nctId":"NCT06738108","phase":"","title":"EKOS in Patients With Pulmonary Embolism (PE)","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-12-13","conditions":"Pulmonary Embolism","enrollment":104},{"nctId":"NCT03062319","phase":"PHASE4","title":"Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis","status":"TERMINATED","sponsor":"National Hospital Organization Osaka National Hospital","startDate":"2017-04-06","conditions":"Ischemic Stroke, Atrial Fibrillation, Atherothrombosis","enrollment":321},{"nctId":"NCT04559334","phase":"NA","title":"Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients","status":"SUSPENDED","sponsor":"Boston Children's Hospital","startDate":"2020-12-21","conditions":"Central Line Complication, Central Line-associated Bloodstream Infection (CLABSI)","enrollment":15},{"nctId":"NCT03876457","phase":"NA","title":"SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-10-11","conditions":"Acute Ischemic Stroke","enrollment":352},{"nctId":"NCT06680180","phase":"","title":"Fibrinolysis Resistance in Infection and Trauma","status":"RECRUITING","sponsor":"Anders Aneman","startDate":"2024-06-01","conditions":"Sepsis and Septic Shock, Trauma","enrollment":150},{"nctId":"NCT06667882","phase":"NA","title":"Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2021-12-17","conditions":"Pulmonary Embolism Subacute Massive, Complication of Treatment, Fibrinolysis; Hemorrhage","enrollment":33},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT02777580","phase":"PHASE4","title":"STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2017-08-01","conditions":"Myocardial Infarction","enrollment":609},{"nctId":"NCT03581877","phase":"PHASE4","title":"Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwell Health","startDate":"2019-01-28","conditions":"Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism","enrollment":31},{"nctId":"NCT03998319","phase":"PHASE3","title":"A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-10-14","conditions":"STEMI, Elevated IMR (>32)","enrollment":445},{"nctId":"NCT06007222","phase":"PHASE4","title":"Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial","status":"RECRUITING","sponsor":"OCEAN-SHD Study Group","startDate":"2023-04-06","conditions":"Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin","enrollment":400},{"nctId":"NCT05151172","phase":"NA","title":"EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Michael D Hill","startDate":"2022-04-15","conditions":"Acute Ischemic Stroke","enrollment":530},{"nctId":"NCT06034847","phase":"NA","title":"Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy","status":"NOT_YET_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2024-09","conditions":"Stroke, Acute Thrombotic","enrollment":300},{"nctId":"NCT06498323","phase":"PHASE4","title":"Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2022-08-03","conditions":"Intravenous, Thrombosis, Acute Ischemic Stroke","enrollment":160},{"nctId":"NCT06495671","phase":"NA","title":"Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2024-08-01","conditions":"Ischemic Stroke, Stroke","enrollment":30},{"nctId":"NCT06487052","phase":"NA","title":"Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients","status":"RECRUITING","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2024-01-10","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT05203224","phase":"PHASE2","title":"Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-18","conditions":"Ischemic Stroke","enrollment":300}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"PNEUMONIA"},{"count":1,"reaction":"C-REACTIVE PROTEIN INCREASED"},{"count":1,"reaction":"FEBRILE NEUTROPENIA"},{"count":1,"reaction":"GRANULOMA"},{"count":1,"reaction":"PLEURISY"},{"count":1,"reaction":"PLEURITIC PAIN"},{"count":1,"reaction":"PYREXIA"},{"count":1,"reaction":"SEPSIS"},{"count":1,"reaction":"SKIN EXFOLIATION"},{"count":1,"reaction":"WOUND INFECTION"}],"_approvalHistory":[],"publicationCount":1095,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Antithrombotic Agent","genericName":"Antithrombotic Agent","companyName":"Oslo University Hospital","companyId":"oslo-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antithrombotic agents prevent blood clot formation by inhibiting platelet aggregation or coagulation cascade pathways. Used for Thrombotic and thromboembolic disorders (general class indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}